Authors wishing to submit their work to the journal are urged to read this detailed guide for authors and comply with all the requirements, particularly those relating to manuscript length and format. This will speed up the reviewing process and reduce the time taken to publish a paper following acceptance.
ONLINE SUBMISSION
Submission and peer-review of all papers is conducted entirely online, increasing efficiency for editors, authors, and reviewers, and enhancing publication speed.
PUBLICATION WORKFLOW
To speed up and optimize the publication process, EJSOFS adopts this workflow:
ARTICLE TYPES
The following contributions will be accepted for publication. Please take careful note of the maximum length where applicable. Overlength articles will be returned to the authors without peer review:
Please note: Case reports will be considered for publication only if they add new information to the existing body of knowledge or present new points of view on known diseases.
All authors must have contributed to the paper, not necessarily the patient treatment. Technical notes and case reports are limited to a maximum of 4 authors, in exceptional circumstances, 5.
CRITERIA FOR PUBLICATION
Papers that will be considered for publication should be:
MANUSCRIPT PREPARATION GUIDELINES
Papers should follow the specific guidelines applicable:
Structure
Papers must be submitted using the template provided on this page. Papers should be set out as follows, with each section beginning on a separate page:
Please note that the qualifications of the authors will not be included in the published paper. Also, only the surname and initials of authors will appear in the article.
Title
The title page should give the following information:
If the title is longer than 40 characters (including spaces), a short title should be supplied for use in the running heads.
Highlights
Highlights of the paper are three to five bullet points that help increase the discoverability of your article via search engines. These bullet points should capture the novel results of your research as well as new methods that were used during the study (if any). Think of them as the "elevator pitch" of your article. Please include terms that you know your readers will be looking for online. Highlights of the paper will not be published in the article, but will be searchable from the EJSOFS website and can be used for Social Media.
Abstract
200 words maximum. Do not use subheadings or abbreviations; write as a continuous paragraph. Must contain all relevant information and follow the sequence: background, methods, results and conclusion without including sub-headings.
Keywords
Please include a minimum of 5 keywords that are most relevant to the content of your article using the US National Library of Medicine MeSH terms. You can check whether your keywords are MeSH terms here: https://meshb.nlm.nih.gov/search.
Text
Please ensure that the text of your paper conforms to the following structure: Introduction, Materials and Methods, Results, Discussion, Conclusion. Sub-Headings enhance readability but should be appropriate to the nature of the paper. They should be kept to a minimum and may be removed by the Editors.
Introduction
Materials and Methods
Results
Discussion
Conclusion
Abbreviations, acronym, and nomenclature
The acronym/abbreviation/nomenclature should be defined the first time they appear in each of three sections: the abstract; the main text; the first figure or table. When defined for the first time, should be added in parentheses after the written-out form. Only standardized terms, which have been generally accepted, should be used.
Drugs
Drugs: use only generic (non-proprietary) names in the text. Suppliers of drugs used may be named in the Acknowledgments section.
Quantitative analysis
If any statistical methods are used, the text should state the test or other analytical method applied, basic descriptive statistics, critical value obtained, degrees of freedom, and significance level, e.g. (ANOVA, F=2.34; df=3,46; P<0.001). If a computer data analysis was involved, the software package should be mentioned. Descriptive statistics may be presented in the form of a table, or included in the text.
References
References should be numbered consecutively throughout the article, beginning with 1 for the first-cited reference. References should be listed at the end of the paper in the order in which they appear in the text (not listed alphabetically by author). The accuracy of references is the responsibility of the author. References in the text should be numbered with superscript numerals inside punctuation: for example "Mcain and Maffia4 showed..."; "surgery has advantages and disadvantages2-3." Citations in the text to papers with more than two authors should give the name of the first author followed by "et al."; for example: "Chang et al1 verified..." All references cited in the text must be included in the list of references at the end of the paper. Each reference listed must include the names of all authors. Titles of journals should be abbreviated according to Index Medicus (see www.nlm.nih.gov.uk). Please see section "Article Types" for guidance on the maximum number of reference for each type of article. Examples:
Journal Article: Halsband ER, Hirshberg YA, Berg LI. Ketamine hydrochloride in outpatient oral surgery. J Oral Surg 1971: 29: 472-476.
When citing a paper which has a Digital Object Identifier (DOI), use the following style: Toschka H, Feifel H. Aesthetic and functional results of harvesting radial forearm flap. Int J Oral Maxillofac Surg 2001: 30: 45-51. doi: 10.1054/ijom.2000.0005
Book/monograph: Costich ER, White RP. Fundamentals of oral surgery. Philadelphia: WB Saunders, 1971: 201-220.
Book chapter: Hodge HC, Smith FA. Biological properties of inorganic fluorides. In: Simons JH, ed.: Fluorine chemistry. New York: Academic Press, 1965: 135. Internet resource: International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. http://www.icmje.org [Accessibility verified March 21, 2008]
Internet pages and online resources may be included within the text and should state as a minimum the author(s), title and full URL. The date of access should be supplied and all URLs should be checked again at proof stage.
Tables
Figures
Supplementary Material
The recommended upper limit for the size of a single video/animation file is 150 MB, otherwise users may experience problems when downloading the file.
When submitting an article to the European Journal of Stomatology, Oral and Facial Surgery (EJSOFS), authors certify the following clauses:
EDITORIAL POLICY
A paper is accepted for publication on the understanding that it has not been submitted simultaneously to another journal, has been read and approved by all authors, and that the work has not been published before.
DECLARATIONS
Author Contributions
Each author is expected to have made substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data; or the creation of new software used in the work; or have drafted the work or substantively revised it; AND has approved the submitted version (and version substantially edited by journal staff that involves the author’s contribution to the study); AND agrees to be personally accountable for the author’s own contributions and for ensuring that questions related to the accuracy or integrity of any part of the work, even ones in which the author was not personally involved, are appropriately investigated, resolved, and documented in the literature. Upon submission, the corresponding author of the paper must sign the Cover Letter on behalf of all co-authors.
For research articles with several authors, a short paragraph specifying their individual contributions must be provided. The following statements should be used "Conceptualization, X.X. and Y.Y.; Methodology, X.X.; Software, X.X.; Validation, X.X., Y.Y. and Z.Z.; Formal Analysis, X.X.; Investigation, X.X.; Resources, X.X.; Data Curation, X.X.; Writing – Original Draft Preparation, X.X.; Writing – Review & Editing, X.X.; Visualization, X.X.; Supervision, X.X.; Project Administration, X.X.; Funding Acquisition, Y.Y.”
Note: Normally a maximum of five authors should appear on a case report or technical note. If there is a requirement to include additional authors please request this in your cover letter and include the authors in the author contribution form. Minor contributors and non-contributory clinicians who have allowed their patients to be used in the paper should be acknowledged at the end of the text before the references. Please note, a request for exceeding the number of authors is not automatically accepted. The Editor-in-Chief may disagree and require an adjustment.
Funding
All sources of funding of the study should be disclosed. Clearly indicate grants that you have received in support of your research work and if you received funds to cover publication costs. Note that some funders will not refund article processing charges (APC) if the funder and grant number are not clearly and correctly identified in the paper. Funding information can be entered separately into the submission system by the authors during submission of their manuscript. Such funding information, if available, will be deposited to FundRef if the manuscript is finally published.
Please add: “This research received no external funding” or “This research was funded by [name of funder] grant number [xxx]” and “The APC was funded by [XXX]” in this section. Check carefully that the details given are accurate and use the standard spelling of funding agency names at https://search.crossref.org/funding, any errors may affect your future funding.
Institutional Review Board Statement
Please add the Institutional Review Board Statement and approval number for studies involving humans or animals. Please note that the Editorial Office might ask you for further information. Please add “The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Board (or Ethics Committee) of NAME OF INSTITUTE (protocol code XXX and date of approval).” OR “Ethical review and approval were waived for this study, due to REASON (please provide a detailed justification).” OR “Not applicable” for studies not involving humans or animals. You might also choose to exclude this statement if the study did not involve humans or animals.
Informed Consent Statement
Any research article describing a study involving humans should contain this statement. Please add “Informed consent was obtained from all subjects involved in the study.” OR “Patient consent was waived due to REASON (please provide a detailed justification).” OR “Not applicable” for studies not involving humans. You might also choose to exclude this statement if the study did not involve humans.
Written informed consent for publication must be obtained from participating patients who can be identified (including by the patients themselves). Please state “Written informed consent has been obtained from the patient(s) to publish this paper” if applicable. Written consents must be provided to the Editorial Office on request.
Conflicts of Interest
Authors must identify and declare any personal circumstances or interest that may be perceived as influencing the representation or interpretation of reported research results. If there is no conflict of interest, please state "The authors declare no conflict of interest." Any role of the funding sponsors in the choice of research project; design of the study; in the collection, analyses or interpretation of data; in the writing of the manuscript; or in the decision to publish the results must be declared in this section. EJSOFS does not publish studies funded partially or fully by the tobacco industry. Any projects funded by industry must pay special attention to the full declaration of funder involvement. If there is no role, please state “The sponsors had no role in the design, execution, interpretation, or writing of the study”.
Acknowledgements
All contributors who do not meet the criteria for authorship as defined above should be listed in an acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chair who provided only general support. Authors should disclose whether they had any writing assistance and identify the entity providing the assistance (upload the certificate of editing if appropriate) and the funding source for this assistance. Professional language editing service may not be acknowledged in the acknowledgement section if it is a paid service.
Generative artificial intelligence (AI) in scientific writing
The below guidance only refers to the writing process, and not to the use of AI tools to analyse and draw insights from data as part of the research process. This declaration does not apply to the use of basic tools for checking grammar, spelling, references etc. If there is nothing to disclose, there is no need to add a statement.
Where authors use generative AI and AI-assisted technologies in the writing process, authors should only use these technologies to improve readability and language.
Authors must disclose the use of generative AI and AI-assisted technologies in the writing process by adding a statement at the end of their manuscript in the core manuscript file, before the References list. The statement should be placed in a new section entitled ‘Generative AI and AI-assisted technologies in the writing process’.
Statement: During the preparation of this work the author(s) used [NAME TOOL / SERVICE] in order to [REASON]. After using this tool/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the publication.
CHANGES OF AUTHORSHIP
Authors should consider carefully the list and order of authors before submitting their manuscript and provide the full list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Please note that any change must be approved by the Editor-in-Chief. If you require to make a change to the authorship, please email editorial@ejsofs.com with the reasons for the change in authorship.
Requests to add or delete, or rearrange the author list after the manuscript has been accepted will only be considered in exceptional circumstances. While the Editor considers the request, publication of the manuscript will be suspended.
If the manuscript has already been published in an online issue, no requests for authorship amendment will be considered.
Before a paper is accepted the corresponding author of the paper must sign on behalf of all co-authors the Cover Letter form. This form confirms that all the named authors agree to publication if the paper is accepted and that each has had significant input into the paper. Please download the form and send upload it during the submission.
ETHICS
Studies in humans and animals
Any manuscript concerned with human subjects, medical records, or human tissue that is submitted to the European Journal of Stomatology, Oral and Facial Surgery should comply with the principles stated in the Declaration of Helsinki “Ethical Principles for Medical Research Involving ‘Human Subjects”, adopted by the 18th World Medical Assembly, Helsinki, Finland, June 1964, and as amended most recently by the 64th World Medical Assembly, Fontaleza, Brazil, October 2013. The manuscript should be in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aim for the inclusion of representative human populations (sex, age and ethnicity) as per those recommendations. The terms sex and gender should be used correctly.
The manuscript should contain a statement that the work has been approved by the appropriate Ethical Committee related to the institution(s) in which the work was performed, and that subjects gave informed consent to the work. The European Journal of Stomatology, Oral and Facial Surgery requires institutional Ethics Committee approval for all human studies. For retrospective studies of records either a statement of approval or a statement of exemption from the Committee is appropriate. This statement should be provided upon submission of the manuscript.
All animal experiments with must state that their care was in accordance with institution guidelines, ARRIVE guidelines, EU Directive 2010/63/EU for animal experiments, or the National Research Council's Guide for the Care and Use of Laboratory Animals and the authors should clearly indicate in the manuscript that such guidelines have been followed. The sex of animals must be indicated, and where appropriate, the influence (or association) of sex on the results of the study.
Reporting sex- and gender-based analyses
Reporting guidance
For research involving or pertaining to humans, animals or eukaryotic cells, investigators should integrate sex and gender-based analyses (SGBA) into their research design according to funder/sponsor requirements and best practices within a field. Authors should address the sex and/or gender dimensions of their research in their article. In cases where they cannot, they should discuss this as a limitation to their research's generalizability. Importantly, authors should explicitly state what definitions of sex and/or gender they are applying to enhance the precision, rigor and reproducibility of their research and to avoid ambiguity or conflation of terms and the constructs to which they refer (see Definitions section below). Authors can refer to the Sex and Gender Equity in Research (SAGER) guidelines and the SAGER guidelines checklist. These offer systematic approaches to the use and editorial review of sex and gender information in study design, data analysis, outcome reporting and research interpretation - however, please note there is no single, universally agreed-upon set of guidelines for defining sex and gender.
Definitions
Sex generally refers to a set of biological attributes that are associated with physical and physiological features (e.g., chromosomal genotype, hormonal levels, internal and external anatomy). A binary sex categorization (male/female) is usually designated at birth ("sex assigned at birth"), most often based solely on the visible external anatomy of a newborn. Gender generally refers to socially constructed roles, behaviors, and identities of women, men and gender-diverse people that occur in a historical and cultural context and may vary across societies and over time. Gender influences how people view themselves and each other, how they behave and interact and how power is distributed in society. Sex and gender are often incorrectly portrayed as binary (female/male or woman/man) and unchanging whereas these constructs actually exist along a spectrum and include additional sex categorizations and gender identities such as people who are intersex/have differences of sex development (DSD) or identify as non-binary. Moreover, the terms "sex" and "gender" can be ambiguous-thus it is important for authors to define the manner in which they are used. In addition to this definition guidance and the SAGER guidelines, the resources on this page offer further insight around sex and gender in research studies.
Patient confidentiality
Patients have a right to privacy. Therefore identifying information, including patients' images, names, initials, or hospital numbers, should not be included in videos, recordings, written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and you have obtained written informed consent for publication in print and electronic form from the patient (or parent, guardian or next of kin where applicable). If such consent is made subject to any conditions, The Editor and Publisher must be made aware of all such conditions. Written consents must be provided to the Editorial Office on request. Even where consent has been given, identifying details should be omitted if they are not essential. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note. Patient consent is required for the publication of any clinical photographs, and all single case reports, including those where the data is anonymised. If consent for publication has not been obtained, personal details of patients included in any part of the paper and in any supplementary materials (including all illustrations and videos) must be removed before submission.
Registration of clinical trials
EJSOFS follows the International Committee of Medical Journal Editors recommendations which require and recommend registration of clinical trials in a public trials registry at or before the time of first patient enrollment as a condition of consideration for publication. Suitable databases include clinicaltrials.gov, the EU Clinical Trials Register and those listed by the World Health Organisation International Clinical Trials Registry Platform
GUIDELINES FOR REVISED MANUSCRIPTS
In addition to general instructions on what is to be uploaded with a revised manuscript which will be included in the editor's decision letter advising revision, the following is what is required from the editors' and reviewers' point of view to facilitate re-evaluation. Adherence to these guidelines will facilitate and speed up the review process of revised manuscripts.
PROOFS
Once accepted, the manuscript will undergo professional copy-editing, English revision and next proofreading by the authors. All proofreading changes must be made in the Microsoft Word template received and then submitted in a clean and tracked version.
ACCEPTED FILE FORMATS
Authors should use the Microsoft Word template to prepare their manuscript. Using the template file will substantially shorten the time to complete copy-editing and publication of accepted manuscripts. The total amount of data for all files must not exceed 120 MB.
Microsoft Word: When preparing manuscripts in Microsoft Word, you must use the EJSOFS Microsoft Word template file. Please insert your graphics (schemes, figures, etc.) in the main text after the paragraph of its first citation.
OFFPRINTS
All authors will have open access to the article. The corresponding author will receive a version of the article printed, without costs, in their department.
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.